Real World Evidence Generation

Real World Evidence Generation

Real-World Evidence Generation

 With the right technology infrastructure and support and our unique global patient database, you can completely leverag RWE across the world for maximum value. 

Sufficient clinical evidence

As with every aspect of clinical research, the cost of postmarket surveillance and other post-approval studies is rising fast – and in some cases, exceeds projected revenues. Generating and applying real-world evidence (RWE) early in the device development cycle is one way to reduce the costs and delays associated with postmarketing requirements.

RWE is derived from Real-World Data (RWD), which includes data from sources such as electronic health records, registries, and pharmacy and insurance records. Devices are especially good candidates for early RWE use since evidence collected in the context of actual patient care from previously approved versions or similar devices often can be used to supplement findings from clinical trials of the latest version in development.

A good clinical strategy gives you a competitive advantage, by bringing your device to market faster and supporting unique claims with solid clinical evidence.

To make our approach possible and effective, we create our RWE database based on the global patient journey including the different points of care from the diagnostic to the follow-up.

Aggregating retrospective datas (hospitals, nurses, GP, caregivers, etc.)

Soon : generating patient data through specific health apps.